BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23633158)

  • 1. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.
    Wani S; Abrams J; Edmundowicz SA; Gaddam S; Hovis CE; Green D; Gupta N; Higbee A; Bansal A; Rastogi A; Early D; Lightdale CJ; Sharma P
    Dig Dis Sci; 2013 Jun; 58(6):1703-9. PubMed ID: 23633158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
    Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
    Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.
    Ayers K; Shi C; Washington K; Yachimski P
    Surg Endosc; 2013 Aug; 27(8):2836-40. PubMed ID: 23389078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
    Odze RD; Lauwers GY
    Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.
    Rubenstein JH; Sawas T; Wani S; Eluri S; Singh S; Chandar AK; Perumpail RB; Inadomi JM; Thrift AP; Piscoya A; Sultan S; Singh S; Katzka D; Davitkov P
    Gastroenterology; 2024 Jun; 166(6):1020-1055. PubMed ID: 38763697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
    Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists.
    Schölvinck DW; van der Meulen K; Bergman JJGHM; Weusten BLAM
    Endoscopy; 2017 Feb; 49(2):113-120. PubMed ID: 27855466
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?
    Konda VJ; Ferguson MK
    World J Gastroenterol; 2010 Aug; 16(30):3786-92. PubMed ID: 20698041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
    Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
    Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.